Data / Form D filings / Ordaos, Inc.
Ordaos, Inc.: Form D filings
Ordaos, Inc., a biotechnology company in New York, NY, filed 6 Form D notices with the SEC between 2022 and 2025. The latest, on April 1, 2025, reports $337,705 sold of a $2 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 228 Park Avenue S, #60684, New York, NY, 10003
- Phone
- (201) 696-5358
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1933700
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 1, 2025 | New notice | $2,000,000 | $337,705 | $1,662,295 | 3 | Feb 13, 2025 | sec.gov |
| Sep 11, 2024 | New notice | $4,000,000 | $3,104,999 | $895,001 | 5 | Aug 29, 2024 | sec.gov |
| Dec 29, 2023 | New notice | $500,000 | $500,000 | 2 | Dec 22, 2023 | sec.gov | |
| Dec 28, 2023 | New notice | $1,750,000 | $332,000 | $1,418,000 | 4 | Dec 14, 2023 | sec.gov |
| Nov 3, 2023 | New notice | $5,000,000 | $1,800,000 | $3,200,000 | 4 | Mar 8, 2023 | sec.gov |
| Jun 15, 2022 | New notice | $10,742,419 | $10,742,419 | 10 | Jun 2, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ulo Palm | Director | |
| David Longo | Executive Officer, Director | |
| Benjamin Britt | Director | |
| James Ramey | Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Mar 31, 2025 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Ordaos, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.